共 50 条
Drug Delivery Strategies for the Treatment of Metabolic Diseases
被引:39
|作者:
Shi, Sanjun
[1
,2
,3
]
Kong, Na
[1
,2
,3
]
Feng, Chan
[1
,2
,3
]
Shajii, Aram
[1
,2
,3
]
Bejgrowicz, Claire
[1
,2
,3
]
Tao, Wei
[1
,2
,3
]
Forokhzad, Omid C.
[1
,2
,3
]
机构:
[1] Brigham & Womens Hosp, Ctr Nanomed, 75 Francis St, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Anesthesiol, 75 Francis St, Boston, MA 02115 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
关键词:
biomaterials;
drug delivery;
metabolic diseases;
nanomedicine;
LOOP INSULIN DELIVERY;
ONE-POT SYNTHESIS;
ORAL DELIVERY;
POLYMERIC NANOPARTICLES;
CONTROLLED-RELEASE;
MODIFIED LEPTIN;
GLUCOSE;
OBESITY;
INFLAMMATION;
MECHANISMS;
D O I:
10.1002/adhm.201801655
中图分类号:
R318 [生物医学工程];
学科分类号:
0831 ;
摘要:
Metabolic diseases occur when normal metabolic processes are disrupted in the human body, which can be congenital or acquired. The incidence of metabolic diseases worldwide has reached epidemic proportions. So far, various methods including systemic drug therapy and surgery are exploited to prevent and treat metabolic diseases. However, current pharmacotherapeutic options for treatment of these metabolic disorders remain limited and ineffective, especially reducing patient compliance to treatment. Therefore, it is desirable to exploit effective drug delivery approaches to effectively treat metabolic diseases and reduce side effects. This brief review summarizes novel delivery strategies including local, targeted, and oral drug delivery strategies, as well as intelligent stimulus-responsive drug delivery strategy, for the treatment of metabolic disorders including diabetes, obesity, and atherosclerosis.
引用
收藏
页数:14
相关论文